Summit Corporation plc - Product Pipeline Review - 2015

Date: February 28, 2015
Pages: 46
Price:
US$ 1,500.00 US$ 1,200.00
Offer valid until December 31, 2016!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: S30510C3092EN
Leaflet:

Download PDF Leaflet

Summit Corporation plc - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Summit Corporation plc - Product Pipeline Review - 2015’, provides an overview of the Summit Corporation plc’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Summit Corporation plc’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides brief overview of Summit Corporation plc including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Summit Corporation plc’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Summit Corporation plc’s pipeline products
Reasons to buy
  • Evaluate Summit Corporation plc’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Summit Corporation plc in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Summit Corporation plc’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Summit Corporation plc and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Summit Corporation plc
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Summit Corporation plc and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues
Summit Corporation plc Snapshot
Summit Corporation plc Overview
Key Information
Key Facts
Summit Corporation plc - Research and Development Overview
Key Therapeutic Areas
Summit Corporation plc - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Summit Corporation plc - Pipeline Products Glance
Summit Corporation plc - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Summit Corporation plc - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Summit Corporation plc - Drug Profiles
SMT-19969
Product Description
Mechanism of Action
R&D Progress
SMTC-1100
Product Description
Mechanism of Action
R&D Progress
NSI-189
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit O-linked N-acetylglucosaminidase for Neurodegenerative Diseases
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Activate Utrophin for Duchenne Muscular Dystrophy
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Target Utrophin for Duchenne Muscular Dystrophy
Product Description
Mechanism of Action
R&D Progress
SMT-14224
Product Description
Mechanism of Action
R&D Progress
SMT-15000
Product Description
Mechanism of Action
R&D Progress
SMT-21829
Product Description
Mechanism of Action
R&D Progress
SMTC-2100
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit NS3 Helicase for Hepatitis C
Product Description
Mechanism of Action
R&D Progress
Summit Corporation plc - Pipeline Analysis
Summit Corporation plc - Pipeline Products by Target
Summit Corporation plc - Pipeline Products by Route of Administration
Summit Corporation plc - Pipeline Products by Molecule Type
Summit Corporation plc - Pipeline Products by Mechanism of Action
Summit Corporation plc - Recent Pipeline Updates
Summit Corporation plc - Dormant Projects
Summit Corporation plc - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
SMTD-001
Summit Corporation plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Summit Corporation plc, Key Information
Summit Corporation plc, Key Facts
Summit Corporation plc - Pipeline by Indication, 2015
Summit Corporation plc - Pipeline by Stage of Development, 2015
Summit Corporation plc - Monotherapy Products in Pipeline, 2015
Summit Corporation plc - Partnered Products in Pipeline, 2015
Summit Corporation plc - Partnered Products/ Combination Treatment Modalities, 2015
Summit Corporation plc - Out-Licensed Products in Pipeline, 2015
Summit Corporation plc - Out-Licensed Products/ Combination Treatment Modalities, 2015
Summit Corporation plc - Phase II, 2015
Summit Corporation plc - Phase I, 2015
Summit Corporation plc - Preclinical, 2015
Summit Corporation plc - Discovery, 2015
Summit Corporation plc - Pipeline by Target, 2015
Summit Corporation plc - Pipeline by Route of Administration, 2015
Summit Corporation plc - Pipeline by Molecule Type, 2015
Summit Corporation plc - Pipeline Products by Mechanism of Action, 2015
Summit Corporation plc - Recent Pipeline Updates, 2015
Summit Corporation plc - Dormant Developmental Projects,2015
Summit Corporation plc - Discontinued Pipeline Products, 2015
Summit Corporation plc, Subsidiaries

LIST OF FIGURES

Summit Corporation plc - Pipeline by Top 10 Indication, 2015
Summit Corporation plc - Pipeline by Stage of Development, 2015
Summit Corporation plc - Monotherapy Products in Pipeline, 2015
Summit Corporation plc - Partnered Products in Pipeline, 2015
Summit Corporation plc - Pipeline by Top 10 Target, 2015
Summit Corporation plc - Pipeline by Top 10 Route of Administration, 2015
Summit Corporation plc - Pipeline by Top 10 Molecule Type, 2015
Summit Corporation plc - Pipeline Products by Top 10 Mechanism of Action, 2015
Skip to top


Ask Your Question

Summit Corporation plc - Product Pipeline Review - 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: